Related references
Note: Only part of the references are listed.Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species
Jeanneth Mosquera-Rendon et al.
BMC GENOMICS (2016)
Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model
Bahador Behrouz et al.
BURNS (2016)
Biochemical and functional characterization of the periplasmic domain of the outer membrane protein A from enterohemorrhagic Escherichia coli
Haiguang Wang et al.
MICROBIOLOGICAL RESEARCH (2016)
Vaccination against respiratory Pseudomonas aeruginosa infection
Keith Grimwood et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
Paul Warrener et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Specific Humoral Immune Response Induced by Propionibacterium acnes Can Prevent Actinobacillus pleuropneumoniae Infection in Mice
Feng Yang et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients
Stijn Blot et al.
CRITICAL CARE MEDICINE (2014)
Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update
Jean-Louis Vincent
FUTURE MICROBIOLOGY (2014)
Phase separation of myelin sheath in Triton X-114 solution: predominant localization of the 21.5-kDa isoform of myelin basic protein in the lipid raft-associated domain
Michihiro Uruse et al.
JOURNAL OF BIOCHEMISTRY (2014)
AhR sensing of bacterial pigments regulates antibacterial defence
Pedro Moura-Alves et al.
NATURE (2014)
Anti-PcrV Antibody in Cystic Fibrosis: A Novel Approach Targeting Pseudomonas aeruginosa Airway Infection
Carlos E. Milla et al.
PEDIATRIC PULMONOLOGY (2014)
T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis
Hannah K. Bayes et al.
PLOS ONE (2014)
PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury
Qin Wang et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2014)
A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprE/I vaccine (IC43) in healthy volunteers
Kerstin Westritschnig et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Haemolysin Coregulated Protein Is an Exported Receptor and Chaperone of Type VI Secretion Substrates
Julie M. Silverman et al.
MOLECULAR CELL (2013)
Evaluation of the Protective Immunity of a Novel Subunit Fusion Vaccine in a Murine Model of Systemic MRSA Infection
Qian-Fei Zuo et al.
PLOS ONE (2013)
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Shaan L. Gellatly et al.
PATHOGENS AND DISEASE (2013)
Th17-stimulating Protein Vaccines Confer Protection against Pseudomonas aeruginosa Pneumonia
Weihui Wu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Development of a Fourfold Multiplexed Opsonophagocytosis Assay for Pneumococcal Antibodies against Additional Serotypes and Discovery of Serological Subtypes in Streptococcus pneumoniae Serotype 20
Robert L. Burton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: A randomized, double-blind, placebo-controlled trial
Bruno Francois et al.
CRITICAL CARE MEDICINE (2012)
PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice
Y. Song et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Pneumonia Due to Pseudomonas aeruginosa Part II: Antimicrobial Resistance, Pharmacodynamic Concepts, and Antibiotic Therapy
Hsin-Yun Sun et al.
CHEST (2011)
Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity
Kong Chen et al.
IMMUNITY (2011)
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
Qin Lu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development
Zhang Jinyong et al.
MOLECULAR BIOLOGY REPORTS (2011)
Animal models of external traumatic wound infections
Tianhong Dai et al.
VIRULENCE (2011)
Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat
Damien Roux et al.
CRITICAL CARE MEDICINE (2009)
A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
INFECTION AND IMMUNITY (2009)
Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia
Andrew Y. Koh et al.
INFECTION AND IMMUNITY (2009)
Determination of protein oligomerization state: Two approaches based on glutaraldehyde crosslinking
Vasiliki E. Fadoulogiou et al.
ANALYTICAL BIOCHEMISTRY (2008)
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa
Gregory P. Priebe et al.
JOURNAL OF IMMUNOLOGY (2008)
Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A
Tatiana Gartner et al.
IMMUNOLOGY LETTERS (2007)
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
Gerd Doering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever
Henriette Rau et al.
VACCINE (2006)
Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge
AN Neely et al.
BURNS (2005)
Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and Pseudomonas aeruginosa sepsis
J Haberstroh et al.
EUROPEAN SURGICAL RESEARCH (2005)
Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections
U Baumann et al.
VACCINE (2004)
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia
SL Mueller-Ortiz et al.
INFECTION AND IMMUNITY (2004)
Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients
E Mansouri et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung
EES Nieuwenhuis et al.
NATURE MEDICINE (2002)
Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response
C Moser et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Share Paper
